Insiders Prescient Therapeutics Limited

Equities

PTX

AU000000PTX3

Market Closed - Australian S.E. Other stock markets 11:40:51 20/05/2024 am IST			5-day change	1st Jan Change
0.047 ^AUD	+9.30%		+14.63%	-24.19%

25/03	Transcript : Prescient Therapeutics Limited - Special Call
23/02	Prescient Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Prescient Therapeutics Limited Appoints Ellen Feigal to the Board as Non- Executive Director	15/23/15	CI
Prescient Therapeutics Limited Announces Appointments to its Scientific Advisory Board	19/21/19	CI
Prescient Therapeutics Limited Appoints Donald M. O'Rourke to its Scientific Advisory Board	19/21/19	CI
Prescient Therapeutics Limited Appoints H. Miles Prince AM to tis Scientific Advisory Board	17/20/17	CI
Prescient Therapeutics Announces Appointment of Phillip Darcy to Scientific Advisory Board	07/20/07	CI
Prescient Therapeutics Limited Names Allen Ebens as Non-Executive Director, Effective 1 June 2020	01/20/01	CI
Prescient Therapeutics Limited Announces Retirement of Mr. Paul Hopper as Non-Executive Director	02/20/02	CI
Prescient Therapeutics Limited Appoints James Winkler as Vice President - Business Development Based in US	29/18/29	CI
Prescient Therapeutics : CSO named among Top 20 Translational Researchers by Nature	20/17/20	PU
Prescient Therapeutics : Steven Yatomi-Clarke Appointed CEO	15/16/15	PU
Prescient Therapeutics Ltd Appoints Steven Yatomi-Clarke as Chief Executive Officer and Managing Director	15/16/15	CI
Prescient Therapeutics Ltd Appoints Thomas Prebet to its Scientific Advisory Board	14/16/14	CI
Prescient Therapeutics Limited Appoints Jeffrey Lancet to its Scientific Advisory Board	30/15/30	CI
Prescient Therapeutics Limited Appoints Farhad Ravandi to its Scientific Advisory Board	26/15/26	CI
Prescient Therapeutics Limited Announces Resignation of Robert Crombie as Managing Director	15/15/15	CI
Prescient Therapeutics : CSO named among Top 20 Translational Researchers by Nature	03/15/03	PU
Prescient Therapeutics : Distinguished Moffitt Cancer Center Scientist Appointed CSO	26/15/26	PU
M. Sebti Joins Prescient Therapeutics Limited as Chief Scientific Officer	26/15/26	CI
Prescient Therapeutics Limited Appoints Terrence Chewas Chief Medical Officer	28/15/28	CI
Prescient Therapeutics Limited Announces Executive Changes	03/15/03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Prescient Therapeutics Limited

Equities

PTX

AU000000PTX3

Insiders

Filters